Tonic versus phasic pain: dose-related effects of ketoprofen
- PMID: 8751014
- DOI: 10.1007/BF00192351
Tonic versus phasic pain: dose-related effects of ketoprofen
Abstract
Only recently has a new experimental technique been developed which combines tonic and phasic painful stimulation. By means of this technique the non-steroidal anti-inflammatory drug (NSAID) ibuprofen has been shown to produce a dose-related decrease in heterotopically applied phasic and tonic pain. The present study aimed to investigate the dose-related effects of the NSAID ketoprofen (50, 100, and 150 mg i.v.) when tonic and phasic stimuli were applied homotopically. Eighteen healthy volunteers participated in the double-blind, randomized, placebo-controlled study. After an initial training session subjects took part in four experiments, each of which was divided into three sessions (before, 30, and 120 min after drug administration). During each session 45 painful phasic CO2 stimuli of three concentrations were presented to the left nostril in randomized order (duration 200 ms; interval 40 s; 45%, 52%, and 59% v/v CO2). The left nostril was additionally stimulated with a constant stream of dry air, which produced a tonic painful sensation described as dull and burning. Subjects rated the intensity of the painful stimuli by means of visual analogue scales. Chemosomatosensory event-related potentials (CSSERPs) were recorded in response to phasic painful CO2 stimuli. Ketoprofen reduced the subjects' estimates of tonic pain in a dose-related manner. In contrast, given the special conditions of homotopic application of tonic and phasic painful stimuli, estimates of phasic pain increased significantly, corresponding to a significant increase in CSSERP amplitudes. An explanation of this inverse effect of the drug on responses to tonic and phasic pain may be a lateralized interaction between both C-fiber and A delta-fiber systems at a spinal or peripheral level.
Similar articles
-
Dose-related effects of ibuprofen on pain-related potentials.Br J Clin Pharmacol. 1994 May;37(5):445-52. doi: 10.1111/j.1365-2125.1994.tb05712.x. Br J Clin Pharmacol. 1994. PMID: 8054250 Free PMC article. Clinical Trial.
-
Effects of azapropazone on pain-related brain activity in human subjects.Br J Clin Pharmacol. 1995 Dec;40(6):545-52. doi: 10.1111/j.1365-2125.1995.tb05799.x. Br J Clin Pharmacol. 1995. PMID: 8703660 Free PMC article. Clinical Trial.
-
The negative mucosal potential: separating central and peripheral effects of NSAIDs in man.Eur J Clin Pharmacol. 1997;52(5):359-64. doi: 10.1007/s002280050301. Eur J Clin Pharmacol. 1997. PMID: 9272404 Clinical Trial.
-
Topical ketoprofen patch.Drugs R D. 2005;6(6):337-44. doi: 10.2165/00126839-200506060-00003. Drugs R D. 2005. PMID: 16274258 Review.
-
Preclinical and clinical development of dexketoprofen.Drugs. 1996;52 Suppl 5:24-45; discussion 45-6. doi: 10.2165/00003495-199600525-00005. Drugs. 1996. PMID: 8922555 Review.
Cited by
-
Electroencephalography and analgesics.Br J Clin Pharmacol. 2014 Jan;77(1):72-95. doi: 10.1111/bcp.12137. Br J Clin Pharmacol. 2014. PMID: 23593934 Free PMC article. Review.
-
Tonic stimulation of the pharyngeal mucosa causes pain and a reversible increase of inflammatory mediators.Inflamm Res. 2013 Dec;62(12):1045-51. doi: 10.1007/s00011-013-0663-7. Epub 2013 Sep 15. Inflamm Res. 2013. PMID: 24037371 Free PMC article.
-
Comparison of the antinociceptive activity of two new NO-releasing derivatives of the NSAID S-ketoprofen in rats.Br J Pharmacol. 2004 Nov;143(5):533-40. doi: 10.1038/sj.bjp.0705958. Epub 2004 Sep 27. Br J Pharmacol. 2004. PMID: 15451773 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical